Antidepressant Adult Suicidality Labeling To Be Presented For Advisory Committee Review
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will present potential labeling changes on antidepressant-related suicidality in adults at Dec. 13 PDAC meeting.